


cryptorichhh
VERO starting to look bullish. I have outlined two targets that I will be looking at. LONG.
Pot stock providing the software solutions for cannabis companies to expand. They have strong revenue growth and will be the leading pot stock in the next run. LONG.
Keeping it simple, undervalued pot stock, outlined 3 major resistance levels ahead, LONG.
Check out my previous analysis on TLRY, same idea. More legalization talks around cannabis this year with Democratic majorities in the U.S government. Potential buyout here as well.
2021 Democratic government should be more talks around the widespread decriminalization of cannabis will support this stock. Trying to start a new trend higher. Long support and sell on resistance.
LYFT starting to move after a POST IPO dump. Looks good on the long side taking into consideration UBERs recent move above its IPO level. Entering the Food business, I believe further government regualtion will be good for the stock. Potential double bottom, trade into $50 resistance level.
I have out lined the following TP: 50.00 SL: Below local HTF support. Pfizer sitting on fib support follow news of corona virus vaccine. It is reasonable to assume a break of ATH's in the future. Pays a good dividend in addition to the projected upside.
Clear and simple. Held support above $20 after a 250% run after approval. Looking to swing trade to 27.00 ahead of major catalysts.
Take profit 1: 7.50 Take profit 2: 10.00 FDA decision on the companies product Twirla. Womans contraceptive patch BRUDAC ADcomm voted 14-1 in favor. 200mmil marketcap with a 4bill addressable market. Chasing approval since 2013. Approval IS NOT for certain. They could be issued a CRL. Could go much higher on approval. Manage your risk accordingly.
Stock is making higher lows, finding resistance at the $9 level. Awaiting data for Phase 3 trial. killcvmshorts.com for more information. HIGH reward. All or nothing. Looking good for a long setup.
Buy low sell high. Showing signs of a bottom. 2018 4.00 support level looks to be tested which computes a 50% upside from current levels. Could experience an echo bubble type move like other equities have in the past. Pot stocks starting to get a little more attention recently.
ITCI up 20% on the week and further 30% upside ahead! Looking to test 2019 resistance area around 14.50 ahead of its scheduled PDUFA approval on Dec.27th. TP 2 16.50.
Traded in a 7 month range. Company plans on making 30million for the fiscal year 2021. 100mill marketcap so IT IS considered undervalued. TP at 2.40. TP 2 3.50. SL 1.60.
Company showing solid Y/Y growth. We are testing long time overhead resistance. Wait for a break and long to $168. 13-15% upside. Coming off a good ER and bouncing off critical support. Y/Y Revenue 1.73B 28.03% Net income 241M 460.47% Diluted EPS 0.36 ...
TWTR has been a buy under $30 ever since 2018, twtr stock was punished for missing last ER, and I believe as a result it has presented us a buying opportunity to ride it back to 35 which computes a 15% upside from the current levels. This company has established its place among the social media giants. It is not going anywhere and will continue to grow. Buy...
This is a long setup for CLDR. Undefined timeframe. Any dips below $8 is a buy opportunity. This is a $18 stock one year from now. Many catalysts for speculation. Undervalued company.
Bottomed at $5.00 and is now in price discovery mode. First target is 12.00. Good volume. More news to come.
This company is currently in Phase 3 of a pre treatment autoimmune therapy drug multikine that is aiming to improve your chances of chemo therapy by 10%. Results are expected within the next 6-12 months. And it could really hit a home run on the back of Phase 3 results. In the short term I expect investors to start taking bets and a test of the 10 level once...